ArticleBMC medicine2024

LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated β-catenin dephosphorylation in a subset of stem-like bladder cancer cells.

Hongjin Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.